<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02710916</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2015/20</org_study_id>
    <nct_id>NCT02710916</nct_id>
  </id_info>
  <brief_title>SD-OCT Multimodal Analysis in GLaucoma</brief_title>
  <acronym>SOMAL</acronym>
  <official_title>SD-OCT Multimodal Analysis in GLaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma is the first cause of irreversible blindness worldwide with more than 60 millions
      people affected in 2010. It is defined as a neurodegenerative disease characterized by a
      progressive loss of retinal ganglion cells (RGC), visual field deterioration and optic nerve
      excavation. Intraocular pressure (IOP) is the most common risk factor. Despite its severity,
      its impact on quality of life and an existing treatment that can delay visual field damages,
      there is no recommended strategy to screen the disease. Clinical evaluation of optic nerve
      head excavation performed either by ophthalmologists or glaucoma specialists is highly
      inter-observer dependent and limits its accuracy to diagnose glaucoma. Additionally, up to 30
      to 40% of nerve fiber layer may be lost before detecting first visual field defects, thus
      making this tool not accurate enough for screening purposes.

      Spectral-Domain Optical coherence tomography (SD-OCT) imaging technology allows precise and
      reproducible measurements of optic nerve head structures and retinal layers mainly related to
      the speed of acquisition and an axial resolution of 5 microns. New SD-OCT parameters have
      been developed to improve its diagnostic accuracy for glaucoma disease. The investigators
      therefore investigate performances of SD-OCT to discriminate glaucoma patients and controls.
      All subjects will undergo SD-OCT imaging (Spectralis™ OCT, Version 6.3, Heidelberg
      Engineering, Germany) and other study procedures in one single visit. All examinations
      performed on the subjects are non-significant risk.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 22, 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">February 22, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of Bruch's Membrane Opening Minimum Rim Width</measure>
    <time_frame>1 day</time_frame>
    <description>Diagnostic accuracy of SD-OCT to discriminate perimetric, preperimetric glaucoma patients and control patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Retinal Nerve Fiber Layer Thickness</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <condition>Eye Diseases</condition>
  <arm_group>
    <arm_group_label>perimetric glaucoma patients</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>preperimetric glaucoma patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>perimetric glaucoma control patients</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SD-OCT Spectralis</intervention_name>
    <description>All patients will undergo a complete ophthalmological examination with SD-OCT complete evaluation</description>
    <arm_group_label>perimetric glaucoma patients</arm_group_label>
    <arm_group_label>preperimetric glaucoma patients</arm_group_label>
    <arm_group_label>perimetric glaucoma control patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Normal Subjects

          1. No history or evidence of retinal pathology or glaucoma

          2. Normal Humphrey 24-2 Visual Field (VF) : A mean defect (MD), corrected pattern
             standard deviation (CPSD) within 95% limits of normal reference, and glaucoma
             hemifield test (GHT) within normal limits (97%).

          3. Intraocular pressure &lt; 21 mm Hg

          4. Open angle (Shaffer's grading system)

          5. Normal appearing Optic Nerve Hypoplasia (ONH) and Nerve Fiber Layer (NFL) : intact
             neuroretinal rim without peripapillary hemorrhages, notches, localized pallor, or NFL
             defect

          6. Symmetric ONH between left and right eyes: Cup-to-Disc Ratio (CDR) difference &lt; 0.2 in
             both vertical and horizontal dimensions

        Inclusion Criteria: Perimetric Glaucoma

          1. ONH or NFL defect visible on slit-lamp biomicroscopy defined as one of following:

               -  diffuse or localized thinning of the rim

               -  disc (splinter) hemorrhage

               -  notch in the rim

               -  vertical cup/disc ratio greater than the fellow eye by &gt; 0.2

          2. Consistent glaucomatous pattern on both qualifying Humphrey Swedish Interactive
             Threshold Algorithm (SITA) 24-2 VF meeting at least one of the following quantitative
             criteria for abnormality:

               -  PSD outside normal limits (p &lt; 0.05)

               -  GHT outside normal limits (p &lt; 0.01)

        Inclusion Criteria: Pre-Perimetric Glaucoma (PPG)

        PPG participants must have at least one eye meeting all of the following criteria:

          1. ONH or NFL defect visible on slit-lamp biomicroscopy defined as one of following:

               -  diffuse or localized thinning of the rim

               -  disc (splinter) hemorrhage

               -  notch in the rim

               -  well-defined peripapillary NFL bundle defect.

               -  inter-eye vertical CDR asymmetry &gt; 0.2

          2. Baseline VF not meeting the criteria for the PG group.

          3. Risk factors for glaucoma, one of following:

               -  Intraocular pressure &gt; 21 mm Hg

               -  Ethnics

               -  Family history of glaucoma

        Exclusion Criteria: All Groups

          1. Age &lt; 40

          2. Refractive error of &gt; +6.00 D or &lt; -6.00 D (SE), +3,00 D for astigmatism

          3. Diabetic retinopathy

          4. Other diseases that may cause VF loss or optic disc abnormalities

          5. Inability to clinically view or photograph the optic discs due to media opacity or
             poorly dilating pupil

          6. Inability to perform reliably on automated VF testing

          7. Insufficient quality of Spectralis OCT images (this is not determined until after
             Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:

               -  Retina completely included in image frame,

               -  Quality Score ≥ 15 in the stored mean images,

          8. Refusal of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Bordeaux Hospital</name>
      <address>
        <city>Bordeaux</city>
        <state>Aquitaine</state>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004 May 22;363(9422):1711-20. Review.</citation>
    <PMID>15158634</PMID>
  </reference>
  <reference>
    <citation>Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992 Oct;99(10):1499-504.</citation>
    <PMID>1454314</PMID>
  </reference>
  <reference>
    <citation>Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991 Aug;109(8):1090-5.</citation>
    <PMID>1867550</PMID>
  </reference>
  <reference>
    <citation>Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980 May-Jun;24(Suppl):335-610.</citation>
    <PMID>7444756</PMID>
  </reference>
  <reference>
    <citation>Leung CK, Lam S, Weinreb RN, Liu S, Ye C, Liu L, He J, Lai GW, Li T, Lam DS. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection. Ophthalmology. 2010 Sep;117(9):1684-91. doi: 10.1016/j.ophtha.2010.01.026. Epub 2010 Jul 21.</citation>
    <PMID>20663563</PMID>
  </reference>
  <reference>
    <citation>Leung CK, Choi N, Weinreb RN, Liu S, Ye C, Liu L, Lai GW, Lau J, Lam DS. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: pattern of RNFL defects in glaucoma. Ophthalmology. 2010 Dec;117(12):2337-44. doi: 10.1016/j.ophtha.2010.04.002. Epub 2010 Aug 3.</citation>
    <PMID>20678802</PMID>
  </reference>
  <reference>
    <citation>Windisch BK, Harasymowycz PJ, See JL, Chauhan BC, Belliveau AC, Hutchison DM, Nicolela MT. Comparison between confocal scanning laser tomography, scanning laser polarimetry and optical coherence tomography on the ability to detect localised retinal nerve fibre layer defects in glaucoma patients. Br J Ophthalmol. 2009 Feb;93(2):225-30. doi: 10.1136/bjo.2008.141945. Epub 2008 Sep 2.</citation>
    <PMID>18765430</PMID>
  </reference>
  <reference>
    <citation>Alasil T, Wang K, Yu F, Field MG, Lee H, Baniasadi N, de Boer JF, Coleman AL, Chen TC. Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: a broken stick model. Am J Ophthalmol. 2014 May;157(5):953-59. doi: 10.1016/j.ajo.2014.01.014. Epub 2014 Jan 30.</citation>
    <PMID>24487047</PMID>
  </reference>
  <reference>
    <citation>Horn FK, Mardin CY, Laemmer R, Baleanu D, Juenemann AM, Kruse FE, Tornow RP. Correlation between local glaucomatous visual field defects and loss of nerve fiber layer thickness measured with polarimetry and spectral domain OCT. Invest Ophthalmol Vis Sci. 2009 May;50(5):1971-7. doi: 10.1167/iovs.08-2405. Epub 2009 Jan 17.</citation>
    <PMID>19151389</PMID>
  </reference>
  <reference>
    <citation>Leaney J, Healey PR, Lee M, Graham SL. Correlation of structural retinal nerve fibre layer parameters and functional measures using Heidelberg Retinal Tomography and Spectralis spectral domain optical coherence tomography at different levels of glaucoma severity. Clin Exp Ophthalmol. 2012 Nov;40(8):802-12. doi: 10.1111/j.1442-9071.2012.02807.x. Epub 2012 Jul 2.</citation>
    <PMID>22594488</PMID>
  </reference>
  <reference>
    <citation>Chauhan BC, O'Leary N, AlMobarak FA, Reis ASC, Yang H, Sharpe GP, Hutchison DM, Nicolela MT, Burgoyne CF. Enhanced detection of open-angle glaucoma with an anatomically accurate optical coherence tomography-derived neuroretinal rim parameter. Ophthalmology. 2013 Mar;120(3):535-543. doi: 10.1016/j.ophtha.2012.09.055. Epub 2012 Dec 23.</citation>
    <PMID>23265804</PMID>
  </reference>
  <reference>
    <citation>Bussel II, Wollstein G, Schuman JS. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br J Ophthalmol. 2014 Jul;98 Suppl 2:ii15-9. doi: 10.1136/bjophthalmol-2013-304326. Epub 2013 Dec 19. Review.</citation>
    <PMID>24357497</PMID>
  </reference>
  <reference>
    <citation>Almobarak FA, O'Leary N, Reis AS, Sharpe GP, Hutchison DM, Nicolela MT, Chauhan BC. Automated segmentation of optic nerve head structures with optical coherence tomography. Invest Ophthalmol Vis Sci. 2014 Feb 26;55(2):1161-8. doi: 10.1167/iovs.13-13310.</citation>
    <PMID>24474272</PMID>
  </reference>
  <reference>
    <citation>Wu H, de Boer JF, Chen TC. Diagnostic capability of spectral-domain optical coherence tomography for glaucoma. Am J Ophthalmol. 2012 May;153(5):815-826.e2. doi: 10.1016/j.ajo.2011.09.032. Epub 2012 Jan 20.</citation>
    <PMID>22265147</PMID>
  </reference>
  <reference>
    <citation>Wu H, de Boer JF, Chen TC. Reproducibility of retinal nerve fiber layer thickness measurements using spectral domain optical coherence tomography. J Glaucoma. 2011 Oct;20(8):470-6. doi: 10.1097/IJG.0b013e3181f3eb64.</citation>
    <PMID>20852437</PMID>
  </reference>
  <reference>
    <citation>Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF, Chen TC. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma. 2013 Sep;22(7):532-41. doi: 10.1097/IJG.0b013e318255bb4a.</citation>
    <PMID>22549477</PMID>
  </reference>
  <reference>
    <citation>Wessel JM, Horn FK, Tornow RP, Schmid M, Mardin CY, Kruse FE, Juenemann AG, Laemmer R. Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3613-20. doi: 10.1167/iovs.12-9786.</citation>
    <PMID>23633657</PMID>
  </reference>
  <reference>
    <citation>Langenegger SJ, Funk J, Töteberg-Harms M. Reproducibility of retinal nerve fiber layer thickness measurements using the eye tracker and the retest function of Spectralis SD-OCT in glaucomatous and healthy control eyes. Invest Ophthalmol Vis Sci. 2011 May 18;52(6):3338-44. doi: 10.1167/iovs.10-6611.</citation>
    <PMID>21330656</PMID>
  </reference>
  <reference>
    <citation>El Chehab H, Delbarre M, Maréchal M, Rosenberg R, Marill AF, Fénolland JR, Renard JP. [New neuroretinal rim analysis with spectral domain optical coherence tomography, Spectralis (Heidelberg Engineering, Germany). Preliminary study]. J Fr Ophtalmol. 2015 Jan;38(1):46-52. doi: 10.1016/j.jfo.2014.10.004. Epub 2015 Jan 6. French.</citation>
    <PMID>25575418</PMID>
  </reference>
  <reference>
    <citation>Strouthidis NG, Yang H, Fortune B, Downs JC, Burgoyne CF. Detection of optic nerve head neural canal opening within histomorphometric and spectral domain optical coherence tomography data sets. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):214-23. doi: 10.1167/iovs.08-2302. Epub 2008 Aug 8.</citation>
    <PMID>18689697</PMID>
  </reference>
  <reference>
    <citation>Strouthidis NG, Grimm J, Williams GA, Cull GA, Wilson DJ, Burgoyne CF. A comparison of optic nerve head morphology viewed by spectral domain optical coherence tomography and by serial histology. Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1464-74. doi: 10.1167/iovs.09-3984. Epub 2009 Oct 29.</citation>
    <PMID>19875649</PMID>
  </reference>
  <reference>
    <citation>Strouthidis NG, Yang H, Downs JC, Burgoyne CF. Comparison of clinical and three-dimensional histomorphometric optic disc margin anatomy. Invest Ophthalmol Vis Sci. 2009 May;50(5):2165-74. doi: 10.1167/iovs.08-2786. Epub 2009 Jan 10.</citation>
    <PMID>19136694</PMID>
  </reference>
  <reference>
    <citation>Downs JC, Roberts MD, Burgoyne CF. Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci. 2008 Jun;85(6):425-35. doi: 10.1097/OPX.0b013e31817841cb. Review.</citation>
    <PMID>18521012</PMID>
  </reference>
  <reference>
    <citation>Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 2005 Jan;24(1):39-73. Review.</citation>
    <PMID>15555526</PMID>
  </reference>
  <reference>
    <citation>Burgoyne CF, Morrison JC. The anatomy and pathophysiology of the optic nerve head in glaucoma. J Glaucoma. 2001 Oct;10(5 Suppl 1):S16-8. Review.</citation>
    <PMID>11890263</PMID>
  </reference>
  <reference>
    <citation>Johnstone J, Fazio M, Rojananuangnit K, Smith B, Clark M, Downs C, Owsley C, Girard MJ, Mari JM, Girkin CA. Variation of the axial location of Bruch's membrane opening with age, choroidal thickness, and race. Invest Ophthalmol Vis Sci. 2014 Mar 28;55(3):2004-9. doi: 10.1167/iovs.13-12937.</citation>
    <PMID>24595390</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2016</study_first_submitted>
  <study_first_submitted_qc>March 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2016</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Intraocular pressure</keyword>
  <keyword>Optic Nerve Head</keyword>
  <keyword>Nerve fiber layer</keyword>
  <keyword>Bruch Membrane Opening -Minimum Rim Width</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

